CN107455739A - A kind of three high drop health care nutrition powder - Google Patents
A kind of three high drop health care nutrition powder Download PDFInfo
- Publication number
- CN107455739A CN107455739A CN201710600773.7A CN201710600773A CN107455739A CN 107455739 A CN107455739 A CN 107455739A CN 201710600773 A CN201710600773 A CN 201710600773A CN 107455739 A CN107455739 A CN 107455739A
- Authority
- CN
- China
- Prior art keywords
- powder
- parts
- health care
- blood
- raw material
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000843 powder Substances 0.000 title claims abstract description 91
- 230000036541 health Effects 0.000 title claims abstract description 23
- 235000016709 nutrition Nutrition 0.000 title claims abstract description 23
- 230000035764 nutrition Effects 0.000 title claims abstract description 23
- 239000002994 raw material Substances 0.000 claims abstract description 19
- 235000010469 Glycine max Nutrition 0.000 claims abstract description 10
- 244000068988 Glycine max Species 0.000 claims abstract description 10
- 244000077995 Coix lacryma jobi Species 0.000 claims abstract description 8
- 235000009917 Crataegus X brevipes Nutrition 0.000 claims abstract description 8
- 235000013204 Crataegus X haemacarpa Nutrition 0.000 claims abstract description 8
- 235000009685 Crataegus X maligna Nutrition 0.000 claims abstract description 8
- 235000009444 Crataegus X rubrocarnea Nutrition 0.000 claims abstract description 8
- 235000009486 Crataegus bullatus Nutrition 0.000 claims abstract description 8
- 235000017181 Crataegus chrysocarpa Nutrition 0.000 claims abstract description 8
- 235000009682 Crataegus limnophila Nutrition 0.000 claims abstract description 8
- 240000000171 Crataegus monogyna Species 0.000 claims abstract description 8
- 235000004423 Crataegus monogyna Nutrition 0.000 claims abstract description 8
- 235000002313 Crataegus paludosa Nutrition 0.000 claims abstract description 8
- 235000009840 Crataegus x incaedua Nutrition 0.000 claims abstract description 8
- 229920002752 Konjac Polymers 0.000 claims abstract description 8
- 244000046146 Pueraria lobata Species 0.000 claims abstract description 8
- 235000010575 Pueraria lobata Nutrition 0.000 claims abstract description 8
- 244000269722 Thea sinensis Species 0.000 claims abstract description 8
- 240000000851 Vaccinium corymbosum Species 0.000 claims abstract description 8
- 235000003095 Vaccinium corymbosum Nutrition 0.000 claims abstract description 8
- 235000017537 Vaccinium myrtillus Nutrition 0.000 claims abstract description 8
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 claims abstract description 8
- 235000021014 blueberries Nutrition 0.000 claims abstract description 8
- 239000000835 fiber Substances 0.000 claims abstract description 8
- 235000013312 flour Nutrition 0.000 claims abstract description 8
- 235000009569 green tea Nutrition 0.000 claims abstract description 8
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 claims abstract description 8
- 102000004169 proteins and genes Human genes 0.000 claims abstract description 8
- 108090000623 proteins and genes Proteins 0.000 claims abstract description 8
- 235000010447 xylitol Nutrition 0.000 claims abstract description 8
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 claims abstract description 8
- 229960002675 xylitol Drugs 0.000 claims abstract description 8
- 239000000811 xylitol Substances 0.000 claims abstract description 8
- 229920002774 Maltodextrin Polymers 0.000 claims abstract description 7
- 239000005913 Maltodextrin Substances 0.000 claims abstract description 7
- 229940035034 maltodextrin Drugs 0.000 claims abstract description 7
- CAXNYFPECZCGFK-UHFFFAOYSA-N 2-phenyl-2-pyridin-2-ylacetonitrile Chemical compound C=1C=CC=NC=1C(C#N)C1=CC=CC=C1 CAXNYFPECZCGFK-UHFFFAOYSA-N 0.000 claims abstract description 6
- 229920001353 Dextrin Polymers 0.000 claims 1
- 239000004375 Dextrin Substances 0.000 claims 1
- GXCLVBGFBYZDAG-UHFFFAOYSA-N N-[2-(1H-indol-3-yl)ethyl]-N-methylprop-2-en-1-amine Chemical compound CN(CCC1=CNC2=C1C=CC=C2)CC=C GXCLVBGFBYZDAG-UHFFFAOYSA-N 0.000 claims 1
- 235000019425 dextrin Nutrition 0.000 claims 1
- 239000008280 blood Substances 0.000 abstract description 40
- 210000004369 blood Anatomy 0.000 abstract description 40
- 239000008103 glucose Substances 0.000 abstract description 13
- 239000000203 mixture Substances 0.000 abstract description 13
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 abstract description 10
- 235000015097 nutrients Nutrition 0.000 abstract description 4
- 230000001077 hypotensive effect Effects 0.000 abstract description 3
- 208000001953 Hypotension Diseases 0.000 abstract description 2
- 230000007407 health benefit Effects 0.000 abstract description 2
- 208000021822 hypotensive Diseases 0.000 abstract description 2
- 235000008935 nutritious Nutrition 0.000 abstract description 2
- 230000003014 reinforcing effect Effects 0.000 abstract description 2
- 210000000952 spleen Anatomy 0.000 abstract description 2
- 210000002784 stomach Anatomy 0.000 abstract description 2
- 150000002632 lipids Chemical class 0.000 description 21
- 235000013305 food Nutrition 0.000 description 20
- 241000699666 Mus <mouse, genus> Species 0.000 description 18
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 17
- 206010020772 Hypertension Diseases 0.000 description 13
- 230000036772 blood pressure Effects 0.000 description 12
- 230000000694 effects Effects 0.000 description 12
- 238000009472 formulation Methods 0.000 description 10
- 206010012601 diabetes mellitus Diseases 0.000 description 8
- 238000012360 testing method Methods 0.000 description 7
- 208000002173 dizziness Diseases 0.000 description 6
- 239000003814 drug Substances 0.000 description 6
- 208000008589 Obesity Diseases 0.000 description 5
- 241000700159 Rattus Species 0.000 description 5
- 201000010099 disease Diseases 0.000 description 5
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 5
- 201000001421 hyperglycemia Diseases 0.000 description 5
- 235000020824 obesity Nutrition 0.000 description 5
- 229940079593 drug Drugs 0.000 description 4
- 230000001965 increasing effect Effects 0.000 description 4
- 238000012856 packing Methods 0.000 description 4
- 208000024891 symptom Diseases 0.000 description 4
- 238000003304 gavage Methods 0.000 description 3
- 230000000291 postprandial effect Effects 0.000 description 3
- 238000011746 C57BL/6J (JAX™ mouse strain) Methods 0.000 description 2
- 241000196324 Embryophyta Species 0.000 description 2
- 241000699670 Mus sp. Species 0.000 description 2
- 230000037396 body weight Effects 0.000 description 2
- 235000013339 cereals Nutrition 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 230000003750 conditioning effect Effects 0.000 description 2
- 238000001514 detection method Methods 0.000 description 2
- 235000005911 diet Nutrition 0.000 description 2
- 230000037213 diet Effects 0.000 description 2
- 235000013325 dietary fiber Nutrition 0.000 description 2
- 239000012153 distilled water Substances 0.000 description 2
- 201000005577 familial hyperlipidemia Diseases 0.000 description 2
- 230000001771 impaired effect Effects 0.000 description 2
- 230000006698 induction Effects 0.000 description 2
- 230000001939 inductive effect Effects 0.000 description 2
- 210000003734 kidney Anatomy 0.000 description 2
- 210000004185 liver Anatomy 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 208000030159 metabolic disease Diseases 0.000 description 2
- 210000000056 organ Anatomy 0.000 description 2
- QCVGEOXPDFCNHA-UHFFFAOYSA-N 5,5-dimethyl-2,4-dioxo-1,3-oxazolidine-3-carboxamide Chemical compound CC1(C)OC(=O)N(C(N)=O)C1=O QCVGEOXPDFCNHA-UHFFFAOYSA-N 0.000 description 1
- 201000001320 Atherosclerosis Diseases 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- 208000017667 Chronic Disease Diseases 0.000 description 1
- 102000002322 Egg Proteins Human genes 0.000 description 1
- 108010000912 Egg Proteins Proteins 0.000 description 1
- 208000008967 Enuresis Diseases 0.000 description 1
- 102000015779 HDL Lipoproteins Human genes 0.000 description 1
- 108010010234 HDL Lipoproteins Proteins 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- 206010022489 Insulin Resistance Diseases 0.000 description 1
- 102000007330 LDL Lipoproteins Human genes 0.000 description 1
- 108010007622 LDL Lipoproteins Proteins 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 206010033645 Pancreatitis Diseases 0.000 description 1
- 206010033647 Pancreatitis acute Diseases 0.000 description 1
- 208000004880 Polyuria Diseases 0.000 description 1
- 206010062237 Renal impairment Diseases 0.000 description 1
- 208000034189 Sclerosis Diseases 0.000 description 1
- 206010048010 Withdrawal syndrome Diseases 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 201000003229 acute pancreatitis Diseases 0.000 description 1
- 210000001367 artery Anatomy 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 208000026106 cerebrovascular disease Diseases 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 208000029078 coronary artery disease Diseases 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 230000018044 dehydration Effects 0.000 description 1
- 238000006297 dehydration reaction Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 208000016097 disease of metabolism Diseases 0.000 description 1
- 230000035619 diuresis Effects 0.000 description 1
- 230000035622 drinking Effects 0.000 description 1
- 235000014103 egg white Nutrition 0.000 description 1
- 210000000969 egg white Anatomy 0.000 description 1
- 239000003792 electrolyte Substances 0.000 description 1
- 206010016256 fatigue Diseases 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 210000002216 heart Anatomy 0.000 description 1
- 208000019622 heart disease Diseases 0.000 description 1
- 235000008216 herbs Nutrition 0.000 description 1
- 230000010354 integration Effects 0.000 description 1
- 230000003902 lesion Effects 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 230000000116 mitigating effect Effects 0.000 description 1
- 230000000474 nursing effect Effects 0.000 description 1
- 238000013116 obese mouse model Methods 0.000 description 1
- 230000008520 organization Effects 0.000 description 1
- 230000004203 pancreatic function Effects 0.000 description 1
- 208000035824 paresthesia Diseases 0.000 description 1
- 231100000915 pathological change Toxicity 0.000 description 1
- 230000036285 pathological change Effects 0.000 description 1
- 231100000857 poor renal function Toxicity 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000008929 regeneration Effects 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 210000001525 retina Anatomy 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 230000035488 systolic blood pressure Effects 0.000 description 1
- 230000009261 transgenic effect Effects 0.000 description 1
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 description 1
- 208000001072 type 2 diabetes mellitus Diseases 0.000 description 1
- 239000002023 wood Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Mycology (AREA)
- Health & Medical Sciences (AREA)
- Nutrition Science (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Medicines Containing Plant Substances (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Abstract
The invention discloses a kind of three high drop health care nutrition powder, the nutrient powder is made up using oatmeal, soyabean protein powder, Fed Protein Powder of Pea Insteal, green tea powder, konjaku flour, coix seed powder, hawthorn powder, kudzu-vine root powder, corner angle powder, soy bean edible fiber powder, maltodextrin, xylitol, blueberry powder of raw material according to certain weight proportion.Health care nutrition powder of the present invention is by reasonably arranging in pairs or groups, make its nutritious and comprehensive, the medicinal herb componentses of addition act synergistically with other each compositions, acted on invigorating spleen and reinforcing stomach, benefiting qi and nourishing blood and hypotensive, blood fat, blood glucose etc., make its while people's daily nutrition demand is met more can health care, body health benefits.
Description
Technical field
The present invention relates to a kind of health care nutrition powder, specifically a kind of three high drop health care nutrition powder.
Background technology
" three high diseases " refer to hypertension, hyperglycaemia (diabetes) and hyperlipemia.They are that modern society is derived from
" rich man's disease ", possible individualism, it is also possible to interrelated.Such as:Diabetes patient is easy to suffer from hypertension or high blood simultaneously
Fat disease, and high fat of blood is the principal element of artery sclerosis formation and development, arteriosclerotic's blood vessel elasticity difference aggravation blood pressure
Rise.So there are any one of these three illness, the later stage all easily forms " three high diseases ".At present, hypertension, high blood
Fat and hyperglycaemia are referred to as " the invisible killer " of human health, cause heart disease, cerebrovascular disease, kidney trouble generation and death
Most important hazards, it is the most common chronic disease of the mankind.Relevant statistics shows, in the ten big causes of death of Chinese
In, the death rate related to metabolic disease is just up to 35.7%, and the death toll related to " three high " also accounts for total death toll
27%.Hypertension is often accompanied by the organ functional such as fat and sugar metabolic disorder and the heart, brain, kidney and retina or organic changed
Become.High fat of blood is likely to result in atherosclerosis, coronary heart disease, acute pancreatitis etc..Long term hyperglycemia can make each group of whole body
Knit organ and lesion occur, cause the generation of acute and chronic complication, for example, pancreas function exhaustion, dehydration, electrolyte wadding disorderly, nutrition lacks
Weary, resistance decline, impaired renal function, DPN, eyeground pathological changes etc..The World Health Organization once clearly proposed, prevented
The first line of defence of cardiovascular disease is exactly to reduce " three high " and control " three high ".The clinical treatment high to three, typically now with west
Medicine reducing pressure and sugar lipid-lowering medicine, the general side effect of these medicines is big, often once taking just needs to take throughout one's life, it is impossible to it is simultaneous to reach sample
The purpose controlled, and some medicines also have withdrawal reaction.And dietotherapy is the traditional habit of Chinese, conditioning body is reached by diet
Body, the purpose of strong physique, particularly to angiocardiopathy, hyperlipemia, obesity, diabetes, cancer etc. and diet relation
Close modern civilization diseases have good conditioning effect.Therefore have drawn from from the generally edible coarse cereals of people, dietary fiber,
The herbal powder and other plant raw material of integration of drinking and medicinal herbs and conventional auxiliary material research and develop one kind reduce blood pressure, blood fat, blood
The health care nutrition powder of a variety of effects such as sugar has certain market demand.
The content of the invention
It is an object of the invention to provide a kind of three high drop health care nutrition powder, the nutrient powder is eaten with coarse cereals, dietary fiber, medicine
Homologous herbal powder and other plant raw material and conventional auxiliary material are raw material, and rational proportion, nutrition is balanced, and sweet mouthfeel can
Mouthful, blood pressure, blood glucose and blood fat can be effectively reduced, instant, is very suitable for the three high patients daily consumption.
The present invention uses following technical scheme:
A kind of three high drop health care nutrition powder, it is made up of the raw material of following parts by weight:Oatmeal 60-80 parts, soybean egg
White powder 20-30 parts, Fed Protein Powder of Pea Insteal 10-20 parts, green tea powder 10-20 parts, konjaku flour 80-100 parts, coix seed powder 80-100 parts,
Hawthorn powder 30-50 parts, kudzu-vine root powder 30-50 parts, corner angle powder 40-60 parts, soy bean edible fiber powder 20-30 parts, maltodextrin 10-30
Part, xylitol 10-30 parts, blueberry powder 40-60 parts.
Preferably, described three high drop health care nutrition powder is made up of the raw material of following parts by weight:70 parts of oatmeal, soybean
25 parts of albumen powder, 15 parts of Fed Protein Powder of Pea Insteal, 15 parts of green tea powder, 90 parts of konjaku flour, 90 parts of coix seed powder, 40 parts of hawthorn powder, the root of kudzu vine
40 parts of powder, 50 parts of corner angle powder, 25 parts of soy bean edible fiber powder, 20 parts of maltodextrin, 20 parts of xylitol, 50 parts of blueberry powder.
The preparation method of three high drop health care nutrition powder of the present invention is:Each raw material is mixed according to raw material proportioning
Even, sterilizing, packing can obtain finished product.15 grams every bag, used with canteen, warm water is taken after mixing it with water.
The beneficial effects of the invention are as follows:The health care nutrition powder of the present invention makes its nutritious and complete by reasonably arranging in pairs or groups
Face, the medicinal herb componentses of addition act synergistically with other each compositions, have invigorating spleen and reinforcing stomach, benefiting qi and nourishing blood and hypotensive, blood fat, blood
Sugar etc. act on, make its while people's daily nutrition demand is met more can health care, body health benefits.
Embodiment
With reference to specific embodiment, the present invention is described in further detail.
Embodiment 1
A kind of three high drop health care nutrition powder, it is made up of the raw material of following parts by weight:60 parts of oatmeal, soyabean protein powder
20 parts, 10 parts of Fed Protein Powder of Pea Insteal, 10 parts of green tea powder, 80 parts of konjaku flour, 80 parts of coix seed powder, 30 parts of hawthorn powder, 30 parts of kudzu-vine root powder,
40 parts of corner angle powder, 20 parts of soy bean edible fiber powder, 10 parts of maltodextrin, 10 parts of xylitol, 40 parts of blueberry powder.
Above-mentioned each raw material is well mixed according to raw material proportioning, sterilized, packing can obtain finished product.15 grams every bag, with canteen
With warm water is taken after mixing it with water.
Embodiment 2
A kind of three high drop health care nutrition powder, it is made up of the raw material of following parts by weight:80 parts of oatmeal, soyabean protein powder
30 parts, 20 parts of Fed Protein Powder of Pea Insteal, 20 parts of green tea powder, 100 parts of konjaku flour, 100 parts of coix seed powder, 50 parts of hawthorn powder, kudzu-vine root powder 50
Part, 60 parts of corner angle powder, 30 parts of soy bean edible fiber powder, 30 parts of maltodextrin, 30 parts of xylitol, 60 parts of blueberry powder.
Above-mentioned each raw material is well mixed according to raw material proportioning, sterilized, packing can obtain finished product.15 grams every bag, with canteen
With warm water is taken after mixing it with water.
Embodiment 3
A kind of three high drop health care nutrition powder, it is made up of the raw material of following parts by weight:70 parts of oatmeal, soyabean protein powder
25 parts, 15 parts of Fed Protein Powder of Pea Insteal, 15 parts of green tea powder, 90 parts of konjaku flour, 90 parts of coix seed powder, 40 parts of hawthorn powder, 40 parts of kudzu-vine root powder,
50 parts of corner angle powder, 25 parts of soy bean edible fiber powder, 20 parts of maltodextrin, 20 parts of xylitol, 50 parts of blueberry powder.
Above-mentioned each raw material is well mixed according to raw material proportioning, sterilized, packing can obtain finished product.15 grams every bag, with canteen
With warm water is taken after mixing it with water.
Product function experimental study of the present invention
1st, formulation product is to the rise of high lipid food inducing mouse body weight, four items of blood lipid tests Effect study
High blood lipid model is established in kkay mouse, determines and compares various concentrations formulation product to mouse weight and blood fat four
The effect of item.Female 8 week old obesity kkay mouse 18 are chosen, after confirming kkay mouse obesities, are randomly divided into:High lipid food
(fat content 46.5%)+distilled water group (high lipid food group);High lipid food+formula low dose group (low dosage:2mg/10g/
Day), high lipid food+formula high dose group (high dose:8mg/10g/day);Basal feed feeds female 8 week old simultaneously
C57BL/6J mouse 6 (basal feed+distilled water group) are used as Normal group, are administered one month.The experimental result such as institute of table 1
Show.
High lipid food inducing mouse body weight is raised 1 product of the present invention of table and four items of blood lipid tests experimental result
Note:#p<0.05 compared with control group, * p<0.05 compared with food rich in fat group.
Test result in table 1 shows that feeding high lipid food causes easy fat kkay mouse weights to dramatically increase, and gavage
The increase of the kkay mouse weights as caused by high lipid food can be substantially reduced after formulation product, and with the increasing of formula dosage
Add, increased weight gradually reduces.In addition the liver regeneration of kkay mouse is caused by high lipid food, formulation product also has substantially to it
Reduction effect, its liver coefficient also with formula low dosage increase and reduce amplitude increase.Formulation product can significantly reduce kkay
Mouse total cholesterol level, mouse triglyceride level, low-density lipoprotein white level, and also there is increasing high density lipoprotein water
Flat effect, amplitude of variation increase with the increase of formula dosage.
2nd, the mouse blood sugar rise Effect study that formulation product is induced high lipid food
Hyperglycemia model is established in kkay mouse, determines and compares effect of the various concentrations formulation product to blood glucose.Female 8
Week old obesity kkay mouse 18, after confirming kkay mouse obesities, it is randomly divided into:High lipid food (fat content 46.5%)+bis-
Steam water group (diabetes group);High lipid food+formula low dose group (2mg/10g/day);High lipid food+formula high dose group
(8mg/10g/day);Basal feed feeds female 8 week old C57BL/6J mouse 6 (basal feed+distilled water group) conduct simultaneously
Normal group, it is administered one month.Fasting blood-glucose content, random blood sugar content and postprandial blood sugar content are determined respectively, and it is surveyed
Test result is as shown in table 2.
The blood glucose test result of table 2
Control | Diabetes group | It is formulated low dosage | It is formulated high dose | |
Fasting blood-glucose/mM | 5.0±0.3 | 12.8±0.5# | 7.9±0.2* | 6.8±0.4* |
Random blood sugar/mM | 6.4±0.4 | 32.3±0.3# | 16.5±0.3* | 14.1±0.2* |
Postprandial blood sugar/mM | 6.5±0.3 | 23.8±0.6# | 15.1±0.2* | 13.6±0.3* |
Note:#p<0.05 compared with control group, * p<0.05 compared with diabetes group.
After high lipid food nursing induction is susceptible to suffer from the kkay mouse of diabetes B as can be seen from Table 2, mouse blood sugar is significantly
Rise, after gavage is respectively formulated dose product, the blood sugar concentration of kkay mouse can significantly reduce.Fasting blood-glucose detection, random blood
Sugar detection and postprandial blood sugar testing result are shown:Blood glucose reduces degree to be increased with the increase of formula dosage.This is due to that sugar is resistance to
It is necessary stage early stage of diabetes B that amount is impaired, and the kkay glucose tolerance in mice of high fat induction is damaged, and adjusts the ability drop of blood glucose
It is low, insulin resistance is indicated, and give the kkay glucose tolerance in mice after formula impaired mitigation, this is due to having in formulation product
The effect for serving regulation and reducing blood glucose of effect composition.
3rd, formulation product raises Effect study to the blood pressure of transgenic obese mouse
Hypertension model is established in SD rats, judges the foundation of hypertension model:BP > 120mmHg, measure and ratio are less
With the hypotensive activity of concentration formula.The SD rats 24 of male 30 days ages in days, are randomly divided into 3 groups, high lipid food (fat content
46.5%)+distilled water group (high blood pressure group);High lipid food+formula low dose group (100mg/kg/day), high lipid food+match somebody with somebody
Square high dose group (400mg/kg/day);Basal feed feeds 8 (basal feeds+bis- of SD rats of male 30 days ages in days simultaneously
Steam water group) Normal group is used as, it is administered one month.Test result is as shown in table 3.
The hypertension experimental results of table 3
Control | Hypertension group | It is formulated low dosage | It is formulated high dose | |
Blood pressure/mmHg | 112±4 | 190±5 | 175±3 | 160±8 |
High lipid food is fed induced rat systolic pressure compared with normal group and significantly raised as can be seen from Table 3, raises width
Spend up to 69.6%;For gavage formulation product after one month, formula group can significantly reduce the blood pressure of rat, wherein low dosage formula group
Blood pressure reduces by 7.9%, and high dose formula group blood pressure reduces by 15.8%.
Clinical practice example
Example 1:Mr. Li, male, 55 years old, suffer from high fat of blood for many years, once take other blood lipid-lowering medicines, effect is undesirable and secondary
Act on larger;Through taking health care nutrition powder of the present invention, 3 times a day, once a bag, after 20 days, blood fat tends to normal.
Example 2:Sun, man, 47 years old, suffers from hypertension, high fat of blood, with dizziness, uncomfortable in chest, continuously takes nutrient powder of the present invention
Product one month, 3 times a day, once a bag, dizziness, symptom uncomfortable in chest are disappeared, and blood fat and blood pressure is decreased obviously.
Example 3:Cai, female, 65 years old, suffer from high fat of blood, hypertension for many years, feel dizzy, have the pins and needles, the present invention protects through clothes
Strong nutrient powder product 10 days, 3 times a day, once a bag, symptom is clearly better, after be continuing with one week blood fat and blood pressure of this product and survey
Examination is normal to be down to.
Example 4:Lin, female 59 years old, suffer from hyperglycaemia, hypertension, feel dizzy, tired, drink diuresis more, become thin, through taking this
Invention health care nutrition powder product, is used with food and drink, and warm water is taken after mixing it with water, and 3 times a day, once a bag, dizziness, fatigue symptom are obvious after one week
Mitigate, after being continuing with this product 15 days, blood glucose, blood pressure recover normal value.
Example 5:Yao so-and-so, man, 73 years old, with hypertension for many years, patient's headache, dizziness, failure of memory, limbs were numb
Wood, enuresis nocturna increase, are palpitaition, uncomfortable in chest, weak, and after taking product of the present invention 15 days, clinical symptoms substantially mitigate, after continue to take this
After invention product 10 days, blood pressure recovers normal.
Claims (2)
1. a kind of three high drop health care nutrition powder, it is characterised in that it is made up of the raw material of following parts by weight:Oatmeal 60-80
Part, soyabean protein powder 20-30 parts, Fed Protein Powder of Pea Insteal 10-20 parts, green tea powder 10-20 parts, konjaku flour 80-100 parts, coix seed powder
80-100 parts, hawthorn powder 30-50 parts, kudzu-vine root powder 30-50 parts, corner angle powder 40-60 parts, soy bean edible fiber powder 20-30 parts, malt
Dextrin 10-30 parts, xylitol 10-30 parts, blueberry powder 40-60 parts.
2. three high drop health care nutrition powder according to claim 1, it is characterised in that it is by the raw material system of following parts by weight
Into:70 parts of oatmeal, 25 parts of soyabean protein powder, 15 parts of Fed Protein Powder of Pea Insteal, 15 parts of green tea powder, 90 parts of konjaku flour, coix seed powder 90
Part, 40 parts of hawthorn powder, 40 parts of kudzu-vine root powder, 50 parts of corner angle powder, 25 parts of soy bean edible fiber powder, 20 parts of maltodextrin, xylitol 20
Part, 50 parts of blueberry powder.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201710600773.7A CN107455739A (en) | 2017-07-21 | 2017-07-21 | A kind of three high drop health care nutrition powder |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201710600773.7A CN107455739A (en) | 2017-07-21 | 2017-07-21 | A kind of three high drop health care nutrition powder |
Publications (1)
Publication Number | Publication Date |
---|---|
CN107455739A true CN107455739A (en) | 2017-12-12 |
Family
ID=60543932
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201710600773.7A Pending CN107455739A (en) | 2017-07-21 | 2017-07-21 | A kind of three high drop health care nutrition powder |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN107455739A (en) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN110169580A (en) * | 2019-06-26 | 2019-08-27 | 重庆康泉健康管理有限公司 | Adjust metabolism, blood glucose, blood pressure, the comprehensive nutrition powder of blood lipid and preparation method thereof |
CN111802630A (en) * | 2019-04-11 | 2020-10-23 | 陕西优合生物科技有限公司 | Formula for non-medicine conditioning of four-high obesity |
CN112826088A (en) * | 2021-02-05 | 2021-05-25 | 浙江尖峰健康科技有限公司 | Fresh plant-cleaning beverage formula for improving three-high symptoms and preparation method thereof |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103404857A (en) * | 2013-08-13 | 2013-11-27 | 安徽省雷氏农业科技有限公司 | Health-care nutrient powder used for lowering high blood pressure, high blood fat, and high blood sugar |
CN104491350A (en) * | 2014-12-27 | 2015-04-08 | 张标 | Health product capable of regulating health of heart and cerebral vessels and reducing risk of cardiovascular and cerebrovascular diseases |
CN105231258A (en) * | 2015-08-27 | 2016-01-13 | 安徽倮倮米业有限公司 | Sugar-free and high calcium nutritional rice flour and preparation method thereof |
CN105982324A (en) * | 2016-01-07 | 2016-10-05 | 安徽省华银茶油有限公司 | Tea seed polypeptide buccal tablet suitable for people suffering from high blood pressure, high blood fat and high blood glucose |
CN106261763A (en) * | 2016-08-11 | 2017-01-04 | 刘前锋 | A kind of grain dietary fiber meal replacement powder and preparation method thereof |
CN106819993A (en) * | 2017-01-06 | 2017-06-13 | 山东省内分泌与代谢病研究所 | A kind of preparation method of multifunctional konjak meal replacement powder |
-
2017
- 2017-07-21 CN CN201710600773.7A patent/CN107455739A/en active Pending
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103404857A (en) * | 2013-08-13 | 2013-11-27 | 安徽省雷氏农业科技有限公司 | Health-care nutrient powder used for lowering high blood pressure, high blood fat, and high blood sugar |
CN104491350A (en) * | 2014-12-27 | 2015-04-08 | 张标 | Health product capable of regulating health of heart and cerebral vessels and reducing risk of cardiovascular and cerebrovascular diseases |
CN105231258A (en) * | 2015-08-27 | 2016-01-13 | 安徽倮倮米业有限公司 | Sugar-free and high calcium nutritional rice flour and preparation method thereof |
CN105982324A (en) * | 2016-01-07 | 2016-10-05 | 安徽省华银茶油有限公司 | Tea seed polypeptide buccal tablet suitable for people suffering from high blood pressure, high blood fat and high blood glucose |
CN106261763A (en) * | 2016-08-11 | 2017-01-04 | 刘前锋 | A kind of grain dietary fiber meal replacement powder and preparation method thereof |
CN106819993A (en) * | 2017-01-06 | 2017-06-13 | 山东省内分泌与代谢病研究所 | A kind of preparation method of multifunctional konjak meal replacement powder |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN111802630A (en) * | 2019-04-11 | 2020-10-23 | 陕西优合生物科技有限公司 | Formula for non-medicine conditioning of four-high obesity |
CN110169580A (en) * | 2019-06-26 | 2019-08-27 | 重庆康泉健康管理有限公司 | Adjust metabolism, blood glucose, blood pressure, the comprehensive nutrition powder of blood lipid and preparation method thereof |
CN112826088A (en) * | 2021-02-05 | 2021-05-25 | 浙江尖峰健康科技有限公司 | Fresh plant-cleaning beverage formula for improving three-high symptoms and preparation method thereof |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101347193B (en) | Compound rice capable of providing balanced nutrition and preparing art thereof | |
CN102349553B (en) | Health-care coarse-grain flour, dried noodle, and preparation processes thereof | |
CN101637255B (en) | Hypoglycemic nutrition powder | |
CN103099089A (en) | Health-care product for reducing blood sugar and blood pressure, relaxing bowels, losing weight, resisting fatigue and improving sexual function and production technology thereof | |
CN107373376A (en) | A kind of diabetes nutrition formula rice and its preparation and cooking method | |
CN102526478B (en) | Formula of health-care medicine with functions of strengthening immunity and reducing blood sugar | |
CN108391785A (en) | A kind of functionality meal replacement powder and its manufacture craft and application | |
CN107455739A (en) | A kind of three high drop health care nutrition powder | |
CN101305801A (en) | Dendrobium nobile American ginseng capsule | |
CN104855734A (en) | Assisted dog food for fat dogs and preparation method of assisted dog food | |
CN102177993B (en) | Stomach-strengthening and digestion-promoting tea and preparation method thereof | |
CN103609964B (en) | Health-care coarse grain noodles and preparation technology thereof | |
CN103053638B (en) | A kind of flour and method for making thereof recovering islet function elimination insulin resistance | |
CN104106828A (en) | Solid beverage for reducing blood glucose | |
CN109329725A (en) | A kind of vegetarian diet generation meal and preparation method | |
CN107397104A (en) | A kind of barley seedling powder solid beverage and preparation method thereof | |
CN103621889A (en) | Blood glucose reduction vermicelli and silk cocoon juice used by the same, and silk cocoon juice preparation method | |
CN103920140B (en) | A kind of people is with blood sugar lowering Weight-reducing and lipid-lowering compound preparation | |
CN110384240A (en) | Hypoglycemic vitamin and probiotics fermention object powder alimentation composition and its application | |
CN103053944B (en) | A kind of ground rice and method for making thereof recovering islet function elimination insulin resistance | |
CN107125751A (en) | Tortoise powder, preparation method and applications | |
CN110623266A (en) | Health food for assisting in reducing blood sugar and preparation method thereof | |
CN104207121A (en) | Immunity-enhancing, blood-glucose-reducing, blood-pressure-reducing and blood-fat-reducing diet-therapy health-caring product | |
CN108338348A (en) | A kind of nourishing stomach and spleen soup | |
CN103082298A (en) | Health-care food for reducing blood glucose in assisted mode and preparation method thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
WD01 | Invention patent application deemed withdrawn after publication | ||
WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20171212 |